Aberrant Cytokine Activity in the Host Immune Response to COVID-19 Leads to Cytokine Release Syndrome
Since the first cases of COVID-19 were identified in December 2019, the disease has spread across the world, claiming over half a million lives and affecting millions of others. Medical reports emerging from the pandemic illustrate a broad range of patient symptoms due to the host immune response, with evidence increasingly suggesting that cytokine release syndrome (CRS) may be responsible for the more severe complications of COVID-19.
Download this whitepaper to discover why the potential link between CRS and COVID-19-related deaths warrants further investigation, with details on:
- The mechanisms underlying CRS
- Supporting studies
- The tools used to examine the role of CRS
